论文信息 - Larotrectinib is Highly Active in Patients with Advanced Recurrent TRK Fusion Thyroid (TC) and Salivary Gland Cancers (SGC) - 字舞流文

Larotrectinib is Highly Active in Patients with Advanced Recurrent TRK Fusion Thyroid (TC) and Salivary Gland Cancers (SGC)

A. Drilon | R. Doebele | D. Hong | P. Ma | M. Brose | L. Raez | L. Wirth | A. Farago | C. Baik | D. Sohal | C. Albert | M. Cox | N. Ku | Wafik el-Diery